Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionMidwest Professional Planners, LTD.
Latest Disclosed Ownership29,579 shares
Latest Disclosed Value $ 2,368,678
Midwest Professional Planners, LTD. reports 2.03% increase in ownership of EW / Edwards Lifesciences Corporation

On May 5, 2026 - Midwest Professional Planners, LTD. filed a 13F-HR form disclosing ownership of 29,579 shares of Edwards Lifesciences Corporation (MX:EW) valued at $2,368,678 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 28,991 shares of Edwards Lifesciences Corporation. This represents a change in shares of 2.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 29,579 588 2.03 2,369 -4.17 0.5580
2026-02-06 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 28,991 -7,779 -21.16 2,471 -13.57 0.5854
2025-11-04 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 36,770 -681 -1.82 2,860 -2.39 0.6977
2025-08-11 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 37,451 413 1.12 2,929 9.13 0.7713
2025-05-02 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 37,038 254 0.69 2,685 -1.43 0.8354
2025-02-10 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 36,784 2,343 6.80 2,723 19.85 0.8132
2024-11-14 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 34,441 2,551 8.00 2,273 -22.85 0.6948
2024-08-06 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 31,890 260 0.82 2,946 -2.55 0.9844
2024-05-09 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 31,630 -749 -2.31 3,023 22.45 1.0604
2024-02-15 2023-12-31 13F EDWARDS LIFESCIENCES COM 00282E112 32,379 1,481 4.79 2,469 15.33 0.9842
2024-02-15 2023-12-31 13F EDWARDS LIFESCIENCES COM 00282E112 32,379 2,469
2023-11-13 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 30,898 1,763 6.05 2,141 -22.13 0.9627
2023-08-07 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 29,135 2,338 8.72 2,748 24.01 1.2038
2023-05-15 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 26,797 932 3.60 2,217 14.88 1.0845
2023-02-10 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 25,865 1,513 6.21 1,930 -4.13 1.0681
2022-11-10 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 24,352 1,098 4.72 2,012 -9.00 1.2005
2022-08-09 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 23,254 818 3.65 2,211 -16.28 1.2471
2022-05-11 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 22,436 873 4.05 2,641 -5.44 1.2991
2022-02-10 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 21,563 105 0.49 2,793 14.99 1.3568
2021-11-08 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 21,458 -125 -0.58 2,429 8.68 1.2883
2021-08-10 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 21,583 15,039 229.81 2,235 81.12 1.1644
2021-05-17 2021-03-31 13F Edwards Lifesciences COM 28176E108 6,544 -14,970 -69.58 1,234 -37.14 1.2185
2021-03-11 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 21,514 229 1.08 1,963 15.54 1.2095
2020-11-06 2020-09-30 13F Edwards Lifesciences COM 28176E108 21,285 1,027 5.07 1,699 21.36 1.1951
2020-08-14 2020-06-30 13F Edwards Lifesciences COM 28176E108 20,258 13,714 209.57 1,400 13.45 1.1024
2020-05-05 2020-03-31 13F Edwards Lifesciences COM 28176E108 6,544 154 2.41 1,234 -17.24 1.2185
2020-02-11 2019-12-31 13F Edwards Lifesciences COM 28176E108 6,390 -153 -2.34 1,491 3.61 1.2177
2019-11-14 2019-09-30 13F Edwards Lifesciences COM 28176E108 6,543 22 0.34 1,439 19.42 1.2872
2019-08-12 2019-06-30 13F Edwards Lifesciences COM 28176E108 6,521 -2,041 -23.84 1,205 -26.43 1.1179
2019-05-08 2019-03-31 13F Edwards Lifesciences COM 28176E108 8,562 -737 -7.93 1,638 15.03 1.5814
2019-02-13 2018-12-31 13F Edwards Lifesciences COM 28176E108 9,299 -217 -2.28 1,424 -14.06 1.5328
2018-11-13 2018-09-30 13F Edwards Lifesciences COM 28176E108 9,516 155 1.66 1,657 21.57 1.5214
2018-08-10 2018-06-30 13F Edwards Lifesciences COM 28176E108 9,361 -112 -1.18 1,363 3.10 1.2187
2018-05-15 2018-03-31 13F Edwards Lifesciences COM 28176E108 9,473 135 1.45 1,322 25.67 1.1913
2018-02-12 2017-12-31 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 9,338 9,338 1,052 0.9607
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.